CA
TGAN

Cliff Asness’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Cliff Asness’s Portfolio TGAN Stock Details TGAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,191
Closed -$71.8K – 2279
2022
Q4 		$71.8K Sell
13,191
-5,185
-28% -$30.5K ﹤0.01% 2157
2022
Q3 		$92K Buy
+18,376
New +$90.5K ﹤0.01% 2114

Other funds holding TGAN

KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cliff Asness's TGAN Position: Q1 2023 in Review

Cliff Asness sold out of Transphorm, Inc. Common Stock (TGAN) in Q1 2023, closing a stake of 13,191 shares — an estimated $71.8K sold.

Cliff Asness first reported a position in TGAN in Q3 2022 and held it in 2 quarters. The position peaked at $92K in Q3 2022. 39 funds tracked by Wall St. Rank hold TGAN as of Q1 2023.

  • Cliff Asness reported no remaining Transphorm, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Cliff Asness sold 13,191 Transphorm, Inc. Common Stock shares in Q1 2023, an estimated $71.8K.
  • Cliff Asness first reported a position in Transphorm, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Cliff Asness's Transphorm, Inc. Common Stock position peaked at $92K in Q3 2022.
  • 39 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q1 2023.

Based on AQR Capital Management's 13F filing for Q1 2023, filed 15 May 2023.